pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,786 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: adcom×type: phase readout×type: filing×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings285
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05618353: The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

    Sponsor: VA Office of Research and Development. Phase: PHASE4. Conditions: Coronary Artery Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06018337: A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

    Sponsor: DualityBio Inc.. Phase: PHASE3. Conditions: Metastatic Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07353437: Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco)

    Sponsor: Fudan University. Phase: PHASE2. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07417345: Biomechanical Gait Analysis in Low Back Pain

    Sponsor: Arrate Pinto Carral. Phase: . Conditions: Low Back Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07126275: Mirror Journaling App Study

    Sponsor: Child Mind Institute. Phase: NA. Conditions: Depression Symptoms, Anxiety Symptoms

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05435157: Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.

    Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León. Phase: . Conditions: Diabetes Mellitus

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07517601: Erbium-doped Yttrium Aluminum Garnet (Er:YAG) Laser vs Conventional Ceramic Bracket Debonding: A Split-Mouth Clinical Trial

    Sponsor: Saint-Joseph University. Phase: NA. Conditions: Orthodontic Brackets, Pain, Temperature Change, Laser, Healthy Adult

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04709601: Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in Women With Recurring Urinary Tract Infections.

    Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE4. Conditions: Urinary Tract Infections

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06540612: Effects of Aerobic Exercise on Cancer-Related Biomarkers, Functional Capacity, Cognitive Status and Quality of Life in Women With Breast Cancer

    Sponsor: Hasan Kalyoncu University. Phase: NA. Conditions: Breast Cancer Female, Quality of Life, Survivorship

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06545812: Immune Response During the Conservative and Minimal Invasive Treatment of Pain Caused by Lumbar Disc Herniation

    Sponsor: Josip Juraj Strossmayer University of Osijek. Phase: NA. Conditions: Intervertebral Disc Herniation, Back Pain, Analgesic Nephropathy, Inflammatory Response

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04645212: Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

    Sponsor: Adverum Biotechnologies, Inc.. Phase: . Conditions: Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07539181: Disclosing Agents as Photosensitizers in aPDT for Biofilm Control in Children

    Sponsor: University of Nove de Julho. Phase: NA. Conditions: Dental Plaque

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07401719: Effects of Modified Clamshell Exercises in Patients With Hip Osteoarthritis Grade II.

    Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Osteo Arthritis of Hip

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06104228: 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

    Sponsor: Bastiaan Driehuys. Phase: PHASE2. Conditions: Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder), Connective Tissue Diseases

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07434128: Mammogram Pretreatment With Ulipristal Acetate

    Sponsor: OHSU Knight Cancer Institute. Phase: PHASE2. Conditions: Mammography Screening, Breast Density

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06797765: Optical Coherence Tomography Angiography in Neurological Disease

    Sponsor: University of Texas Southwestern Medical Center. Phase: . Conditions: Octa, Stroke, Subarachnoid Hemorrhage, Intracerebral Hemorrhage

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04375800: Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE2. Conditions: Human Immunodeficiency Virus (HIV) Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06271200: Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)

    Sponsor: National Health Research Institutes, Taiwan. Phase: NA. Conditions: Metabolic Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05283200: Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy

    Sponsor: Imad Najm MD. Phase: NA. Conditions: Lifestyle

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03358303: Effects of Telemonitoring on the Outcome of Heart Failure Patients After an Incidence of Acute Decompensation

    Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Heart Failure

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04844827: Pleural Carcinomatosis Tissue Banking

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Pleural Effusion, Malignant

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05245942: Monitoring of the Safety and the Performance of the Endoscopic Cap Electrode (ECE50)

    Sponsor: MED-EL Elektromedizinische Geräte GesmbH. Phase: . Conditions: Vocal Fold Paresis, Laryngeal Dystonia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07398586: The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative Colitis

    Sponsor: Second Affiliated Hospital of Wenzhou Medical University. Phase: PHASE4. Conditions: Ulcerative Colitis (UC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07483073: A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

    Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Colitis, Ulcerative, Crohn Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07147569: TAMBE Japan Post-Marketing Surveillance

    Sponsor: W.L.Gore & Associates. Phase: . Conditions: Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07007169: Mediterranean Diet and Inequality in Early Breast Cancer

    Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark. Phase: PHASE2. Conditions: Early Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07352683: Open TAP-block in Pediatric Abdominal Surgery

    Sponsor: Uppsala University. Phase: NA. Conditions: Pain Management After Surgery

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT03580083: RGX-111 Gene Therapy in Patients With MPS I

    Sponsor: REGENXBIO Inc.. Phase: PHASE1. Conditions: Mucopolysaccharidosis Type I (MPS I), Hurler Syndrome, Hurler-Scheie Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04106466: DBS for TRD With the Medtronic Summit RC+S

    Sponsor: Helen Mayberg, MD. Phase: NA. Conditions: Major Depressive Disorder, Treatment Resistant Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05492422: Central Executive Training and Parent Training for ADHD

    Sponsor: Florida State University. Phase: NA. Conditions: ADHD

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04370522: Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer

    Sponsor: Spanish Breast Cancer Research Group. Phase: . Conditions: Metastatic Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03920722: Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Microscopic Polyangiitis (MPA)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07502729: Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding

    Sponsor: Shanghai Zhongshan Hospital. Phase: . Conditions: Portal Hypertension, Gastroesophageal Varices Hemorrhage, Gastric Varices, Esophageal Varices

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT03123029: Expanded Access to Venetoclax

    Sponsor: AbbVie. Phase: . Conditions: Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin's Lymphoma, Acute Lymphoblastic Leukemia (ALL), Amyloidosis, Plasma Cell Leukemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07411924: Mastication, Cognition, and Nutritional Status in Multiple Sclerosis

    Sponsor: Ondokuz Mayıs University. Phase: . Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06564623: Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

    Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE1. Conditions: Biliary Tract Cancers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07524023: Emotional-distress-based Integrated Care Programme in Patients With Stable COPD

    Sponsor: University of Zurich. Phase: NA. Conditions: COPD, COPD (Chronic Obstructive Pulmonary Disease)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04702880: A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

    Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Extensive-stage Small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00001979: Immune System Related Kidney Disease

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Kidney Disease, Nephrotic Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06681246: The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment

    Sponsor: Weizmann Institute of Science. Phase: NA. Conditions: Obesity, Weight Loss

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00582296: Multi-Organ Screening Recommendations in Patients With Lynch Syndrome

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Lynch Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05362903: A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

    Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Hypercholesterolemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07413042: A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

    Sponsor: Peking University Cancer Hospital & Institute. Phase: PHASE1. Conditions: SCLC, Extensive Stage

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05932342: Improving Cognition of Older Adults in Community Housing

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Aging, Mental Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07218770: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Active Noninfectious Uveitis Affecting the Posterior Segment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07469969: Transcutaneous Auricular Vagus Nerve Stimulation Combined With Tailor-Made Notched Music Training Therapy for Chronic Subjective Tinnitus

    Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: NA. Conditions: Chronic Subjective Tinnitus

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05979441: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

    Sponsor: argenx. Phase: PHASE3. Conditions: Myositis, Active Idiopathic Inflammatory Myopathy, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05302583: Aromatherapy Inhaler Use for HSCT Distress

    Sponsor: Stanford University. Phase: NA. Conditions: Cancer Distress, Cancer Coping, Hematopoetic Stem Cell Transplant, Aromatherapy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03648905: Clinical Laboratory Evaluation of Chronic Autonomic Failure

    Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Parkinson's Disease, Multiple System Atrophy, Autonomic Failure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06642805: Bilio-pancreatic Complications of Congenital Duodenal Obstructions

    Sponsor: University Hospital, Angers. Phase: . Conditions: Duodenal Obstruction

    full page →ctgov ↗
    ← prev
    page 42 of 96
    next →